Future of Lab Conference - Medlab Middle East Congress

Future of Lab Conference

4.75 CMEs & 3.5 CPDs

7 February 2024 | Bangkok room

3 - 6 February 2025

Dubai World Trade Centre

Future of Lab Conference



The Future of Lab track will offer a comprehensive exploration of the evolving landscape of laboratory medicine. The track will delve into the profound impact of Automation, Artificial Intelligence and Blockchain technology showcasing their revolutionary role in streamlining and enhancing lab processes, ensuring utmost reliability. The track will also shed a light on the potential of Liquid Biopsies in Cancer detection, presenting a breakthrough approach to early diagnosis. An in-depth examination of Point-of-Care Testing (POCT) will reveal its transformative effects on rapid diagnosis, patient engagement, and the shift towards decentralized healthcare. With insights into the impact of Precision Medicine, attendees will understand its role in tailoring therapies for individual patients, thereby enhancing health outcomes and redefining the future of medical care 

Key topics:


  • Technological innovations shaping the future of lab medicine 
  • The rise of Automation and Artificial Intelligence in revolutionizing lab processes 
  • Reinventing Data Security and Integrity in Clinical Laboratories through Blockchain technology 
  • Harnessing the potential of Liquid Biopsies for Cancer detection 
  • The transformative impact of POCT on rapid diagnosis, patient engagement, and decentralized healthcare 
  • Cutting-edge Genomic and Molecular diagnostic techniques transforming patient treatment. 
  • Impact of Precision Medicine on tailored therapies and improved health outcomes 

Benefits of attending:


  • Gain valuable insights into the latest technological innovations shaping the future of laboratory medicine  
  • Discuss the impact of Automation and Artificial Intelligence in lab processes  
  • Explore Blockchain security, Liquid Biopsies, and Precision Medicine for improved patient outcomes 
  • Navigate Genomic diagnostics for advanced patient care  



Scientific Co-Chairs:


  • Albarah El-khani, Senior Director - Operations, G42 Healthcare, Abu Dhabi, UAE
  • Dr Nashat Nafouri, Chair - Healthcare Interest Group, Executive Officer, Saudi Quality Council, Jeddah, KSA